Huajian Medical has launched a strategy that positions Ethereum (ETH) as its primary reserve asset, aiming to lead the Hong Kong stock market in ETH holdings.
The company acquired 5,190 ETH valued over 22 million USD and intends to spend an additional 112 million USD. This strategic investment reflects a growing commitment to ETH.
To mitigate risks, Huajian uses financial tools like derivatives and has a total of 880 million USD allocated for purchasing more ETH, targeting a market valuation of 100 billion USD in two years.
Leave a Reply